Page last updated: 2024-12-05

1,3-benzodioxole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,3-Benzodioxole: A Versatile Building Block in Research

**1,3-Benzodioxole** (also known as **methylenedioxybenzene**) is a heterocyclic organic compound with the formula C6H4O2CH2. It is a white solid with a pungent odor. Its structure consists of a benzene ring fused to a five-membered ring containing two oxygen atoms and a methylene bridge (-CH2-).

**Why is 1,3-benzodioxole important for research?**

1. **Found in natural products:** 1,3-Benzodioxole is a common structural motif in a variety of natural products, including:
* **Piperine:** The active compound in black pepper.
* **Sassafras oil:** Used traditionally for its medicinal properties.
* **Safrole:** Found in sassafras and nutmeg.
* **Myristicin:** Found in nutmeg.
* **Apigenin:** A flavonoid found in many fruits and vegetables.
* **Piperine and its derivatives:** Many drugs containing piperine or its derivatives are being studied for potential therapeutic applications, like anti-cancer, anti-inflammatory, and anti-diabetic drugs.

2. **Versatile synthetic building block:** Due to its reactivity and stability, 1,3-benzodioxole serves as a valuable starting material in organic synthesis. It can be easily functionalized through various reactions to produce diverse compounds with potential biological activity.

3. **Applications in medicinal chemistry:** 1,3-Benzodioxole derivatives have demonstrated a wide range of pharmacological properties, including:
* **Antimicrobial activity:** Some compounds show promising activity against bacteria, fungi, and viruses.
* **Anti-inflammatory activity:** Derivatives have been shown to reduce inflammation and pain.
* **Anti-cancer activity:** Certain compounds have been found to exhibit anti-cancer properties by inhibiting tumor growth and proliferation.
* **Neuroprotective effects:** Some derivatives may have potential in treating neurodegenerative diseases like Alzheimer's and Parkinson's.
* **Antioxidant activity:** Derivatives with antioxidant properties can protect cells from damage caused by free radicals.

4. **Environmental applications:** Some 1,3-benzodioxole derivatives have been explored as potential pesticides and herbicides, although their environmental impact needs to be carefully evaluated.

**Key Points:**

* 1,3-benzodioxole is a versatile molecule found in nature and widely used in organic synthesis.
* It serves as a building block for various compounds with biological activity and potential medicinal applications.
* 1,3-benzodioxole derivatives are being explored for diverse applications, including antimicrobial, anti-inflammatory, and anti-cancer treatments.

**Ongoing research focuses on:**

* Developing new and efficient synthetic routes to 1,3-benzodioxole derivatives.
* Studying the structure-activity relationships of 1,3-benzodioxole compounds to optimize their biological activity.
* Evaluating the safety and efficacy of 1,3-benzodioxole derivatives for potential therapeutic use.

Overall, 1,3-benzodioxole is an important and versatile molecule that continues to play a significant role in various fields, including medicinal chemistry, organic synthesis, and environmental science.

1,3-benzodioxole : A benzodioxole consisting of a benzene ring substituted by a the methylenedioxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9229
CHEMBL ID4757380
CHEBI ID38732
SCHEMBL ID8711
SCHEMBL ID5176793
MeSH IDM0120684

Synonyms (64)

Synonym
AKOS000441921
benzene, 1,2-(methylenedioxy)-
1,3-dioxaindan
o-methylenedioxybenzene
nsc30095
1,3-benzodioxole
(methylenedioxy)benzene
1,3-dioxindan
1,2-(methylenedioxy)benzene
benzene,2-[methylenebis(oxy)]-
nsc-30095
3,4-methylenedioxybenzene
274-09-9
benzodioxole
wln: t56 bo do chj
benzene, 1,2-(methylenebis(oxy))-
1,3-benzodioxolane
o-(methylenedioxy)benzene
methylenedioxybenzene
einecs 205-992-0
nsc 30095
benzene, 1,2-methylenedioxy-
ai3-30574
brn 0115506
inchi=1/c7h6o2/c1-2-4-7-6(3-1)8-5-9-7/h1-4h,5h
GHL.PD_MITSCHER_LEG0.1027
1,3-benzodioxole, 99%
1,2-methylenedioxybenzene
CHEBI:38732
2h-1,3-benzodioxole
M0658
f0xll582b8 ,
5-19-01-00434 (beilstein handbook reference)
unii-f0xll582b8
ec 205-992-0
benzo[1,3]dioxole
benzo[d][1,3]dioxole
FT-0606548
FT-0606469
2h-benzo(d)-1,3-dioxolane
benzo[1.3]dioxol
1,2-methylenedioxy-benzene
1.3-benzodioxole
benzo[1,3]dioxol
benzodioxolan
SCHEMBL8711
14-methylhexadecanoicacid
SCHEMBL5176793
DTXSID9051951
Q-200074
benzene, 1,2-[methylenebis(oxy)]-
CS-W020572
mfcd00005818
F1908-0058
Q3544944
AS-18932
BCP11873
AMY3586
D70968
methylenedioxy benzene
bdbm50595121
CHEMBL4757380 ,
EN300-21045
1,3-dioxaindane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzodioxole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)IC50 (µMol)0.94000.00401.966610.0000AID1873209
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
lipid transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid biosynthetic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate metabolic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transmembrane transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transepithelial transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
renal urate salt excretionBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
export across plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
cellular detoxificationBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ABC-type xenobiotic transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
efflux transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP hydrolysis activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATPase-coupled transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
identical protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
protein homodimerization activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
nucleoplasmBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
brush border membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrial membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
membrane raftBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
external side of apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1695183Inhibition of recombinant bovine liver ARGI at 500 uM using L-arginine as substrate incubated for 60 mins by spectroscopic analysis relative to control2020RSC medicinal chemistry, May-01, Volume: 11, Issue:5
Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors.
AID1873209Inhibition of ABCG2 (unknown origin) expressed in human HEK293 cells mediated mitoxantrone efflux assessed as intracellular mitoxantrone level and measured after 30 mins by FACSflow cytometry analysis2022European journal of medicinal chemistry, Jul-05, Volume: 237Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (8.89)18.7374
1990's8 (17.78)18.2507
2000's6 (13.33)29.6817
2010's15 (33.33)24.3611
2020's12 (26.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.03 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.35%)6.00%
Case Studies1 (2.17%)4.05%
Observational0 (0.00%)0.25%
Other43 (93.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]